Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL4882466

Cc1ccc(-c2cc(/C=C/c3ccc4cc(N(C)C)ccc4[n+]3C)no2)cc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.39
PTGS2 P35354 3/20 0.39
AR P10275 2/20 0.39
SYNJ2 O15056 1/20 0.39
MLNR O43193 1/20 0.39
SYNJ1 O43426 1/20 0.39
PGR P06401 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRA2A P08913 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2B P18089 1/20 0.39
CHRM3 P20309 1/20 0.39
MAOA P21397 1/20 0.39
CNR1 P21554 1/20 0.39
TBXA2R P21731 1/20 0.39
SLC6A2 P23975 1/20 0.39
NPY1R P25929 1/20 0.39
HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL4882472 1.00 KCNH2 (0.39) KCNH2PTGS2ARSYNJ2MLNR
SCHEMBL14007203 0.91 AR (0.45) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4886012 0.78 ACHE (0.58) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4886009 0.78 ACHE (0.58) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4878927 0.77 ACHE (0.55) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4878919 0.77 ACHE (0.55) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4885927 0.77 AR (0.44) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4885936 0.77 AR (0.44) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4882455 0.74 AR (0.47) KCNH2PTGS2ARSYNJ2MLNR
Trifluoromethanesulfonic Acid SCHEMBL4882459 0.74 AR (0.47) KCNH2PTGS2ARSYNJ2MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed
EP-1841428-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES Immusol Incorporated (US) 2007-10-10 EP disclosed
WO-2006078754-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES IMMUSOL INCORPORATED (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS KCNH2 756/4885PTGS2 3271/4885AR 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.